Company: MLSS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022276
Chunk: 30

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 30
---
 Interim
Chief Executive Officer of the Company or ten years from the date of grant, whichever shall end first. The Company believes that the
effect of such existing agreements sold in the United States, Canada and to the period after such time Mr. Osser steps down as Interim
Chief Executive Officer of the Company, collectively expand Mr. Osser’s consulting to and support of the Company beyond its Chinese
operations also to include its medical and other products, while enhancing the retention aspects of the Company’s relationship
with Mr. Osser. On May 19, 2021, Mr. Osser resigned as Chief Executive Officer of the Company and assumed the role of Vice Chairman of
the Board. 

Compensation
under the Employment Agreement and the Consulting Agreement is payable for 9.5 years from May 19, 2021. The Company
recorded expenses of $50,000 and $100,000
related to the Employment Agreement for the three and nine months ended September 30, 2025. The Company recorded expenses of $50,000
and $150,000
related to the Employment Agreement for the three and nine months ended September 30, 2024. The Company recorded expenses of
$50,000
and $100,000
related to the Consulting Agreement for the three and nine months ended September 30, 2025. The Company recorded expenses of $50,000
and $150,000
related to the Consulting Agreement for the three and nine months ended September 30, 2024, respectively. Mr. Osser also
owns 2,717,765 shares
of the Company’s stock and 2,481,048
shares to be issued at the termination of his employment agreement.

Dr.
D. Demesmin, Director

As
of February 2024, the University Pain Medicine Center (STEMMEE), of which Dr. D. Demesmin, a Company board member, is
the CEO, agreed to purchase products from the Company under the same terms and conditions applying to other medical
pain clinics in the United States. STEMMEE purchased medical products in the approximate range of $12,000
and $33,000 for
the three and nine months ended September 30, 2025. STEMMEE purchased medical products in the approximate range of $6,000
and $15,000
for